ArticleiScience2026
Microsomal triglyceride transfer protein restricts steroid production in Leydig cells by regulating SREBP2.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testicular Leydig cells produce testosterone. Decreases in serum testosterone reduce bone density, muscle mass, and sexual functions, and increase obesity and cardiovascular disease. Microsomal triglyceride transfer protein (MTP) is critical for lipoprotein secretion by the liver and intestine. MTP is expressed in the Leydig cells of human and mouse testes, but its function is unknown. MTP inhibition, knockdown, and gene ablation in mouse Leydig cells significantly increased steroid secretion after stimulation with cyclic AMP. MTP deficiency enhanced the expression of cholesterol metabolism genes, luteinizing hormone receptor, and steroid biosynthesis genes. Furthermore, MTP deficiency enhanced the expression and activity of SREBP2. ATAC sequencing revealed enhanced binding of SREBP2 to the promoters of genes in cholesterol metabolism and steroid biosynthesis pathways. SREBP2 knockdown in MTP-deficient cells significantly attenuated the cholesterol and progesterone biosynthesis pathways. These studies show that MTP regulates cholesterol and sex hormone production by modulating SREBP2 activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.